IFNB1 and leukemia: Studies have also indicated that HCMV IE1 protein inhibits the transcription of ISGs by sequestering its binding of promyelocytic leukemia (PML) and STAT2, thus decreasing IFN responses while increasing IFN-β tolerance in the virus (Paulus et al., 2006; Kim and Ahn, 2015).